Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/article/10.1007/s40265-019-1054-3/fulltext.html
Reference74 articles.
1. Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, et al. Gram-negative bacterial infections: Research priorities, accomplishments, and future directions of the antibacterial resistance leadership group. Clin Infect Dis. 2017;1:30–5.
2. Kunz AN, Brook I. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy. 2010;56:492–500.
3. Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV, et al. Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2017;61(8):e00883–917.
4. Van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, et al. Colsitin versus ceftazidime-avibactam in the treatment of infections due to carbapebem-resistant Enterobacteriacea. Clin Infect Dis. 2018;66(2):163–71.
5. Wunderlink R, Giamarellos-Bourboulis E, Rahav G, Mathers A, Bassetti M, Solomkin J, et al. Meropenem-vaborbactam vs. best available therapy for carbapenem-resistant Enterobacteriacea infections in Tango II: primary outcomes by site of infection. Open Forum Infect Dis. 2017;4:S536–S537.
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acylated glucopyranosides: FTIR, NMR, FMO, MEP, molecular docking, dynamics simulation, ADMET and antimicrobial activity against bacterial and fungal pathogens;Chemical Physics Impact;2024-12
2. Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem;Humanities and Social Sciences Communications;2024-07-20
3. Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli;Acta Microbiologica et Immunologica Hungarica;2024-07-02
4. Semisynthesis: An Essential Tool for Antibiotics Drug Discovery;ChemistrySelect;2024-06-18
5. Antimicrobials from endophytes as novel therapeutics to counter drug-resistant pathogens;Critical Reviews in Biotechnology;2024-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3